Market Cap

CytoDyn, Inc. Market Capitalization:

$143.0 Million

USD as of July 1, 2024

business CytoDyn, Inc. Company Profile

CytoDyn, Inc. Main Stock Listing

OTC: CYDY

Market Capitalization History of CytoDyn, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of CytoDyn, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $181.6 M -14.52%
Jan. 1, 2023 $212.4 M -47.57%
Jan. 1, 2022 $405.1 M -90.45%
Jan. 1, 2021 $4.24 B 272.48%
Jan. 1, 2020 $1.14 B 204.08%
Jan. 1, 2019 $374.5 M -10.91%
Jan. 1, 2018 $420.4 M -24.66%
Jan. 1, 2017 $558.0 M -35.40%
Jan. 1, 2016 $863.7 M 17.71%
Jan. 1, 2015 $733.8 M 1.05%
Jan. 1, 2014 $726.1 M -5.00%
Jan. 1, 2013 $764.3 M -65.52%
Jan. 1, 2012 $2.22 B 61.11%
Jan. 1, 2011 $1.38 B 12.50%
Jan. 1, 2010 $1.22 B 433.33%
Jan. 1, 2009 $229.3 M -14.29%
Jan. 1, 2008 $267.5 M -50.00%
Jan. 1, 2007 $535.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

CytoDyn, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

CytoDyn, Inc. has the following listings and related stock indices.


Stock: OTC: CYDY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.